GI
ONC

GAMMA Investing’s BeOne Medicines Ltd ONC Stock Holding History

GAMMA Investing’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Buy
86
+21
+32% +$6.19K ﹤0.01% 2732
2026
Q1 		$19.3K Hold
65
– – ﹤0.01% 2731
2025
Q4 		$19.7K Buy
65
+27
+71% +$8.84K ﹤0.01% 2621
2025
Q3 		$12.9K Hold
38
– – ﹤0.01% 2748
2025
Q2 		$9.2K Sell
38
-7
-16% -$1.72K ﹤0.01% 2850
2025
Q1 		$12.2K Sell
45
-22
-33% -$5.14K ﹤0.01% 2648
2024
Q4 		$12.4K Sell
67
-15
-18% -$3.06K ﹤0.01% 2495
2024
Q3 		$18.4K Buy
82
+43
+110% +$7.74K ﹤0.01% 2155
2024
Q2 		$5.56K Sell
39
-7
-15% -$1.08K ﹤0.01% 2533
2024
Q1 		$7.19K Buy
46
+27
+142% +$4.35K ﹤0.01% 2234
2023
Q4 		$2.82K Buy
+19
New +$3.44K ﹤0.01% 2469

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GAMMA Investing's ONC Position: Q2 2026 in Review

GAMMA Investing increased its BeOne Medicines Ltd (ONC) stake by 32% in Q2 2026, buying an estimated $6.19K and bringing the position to 86 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

GAMMA Investing first reported a position in ONC in Q4 2023 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • GAMMA Investing held 86 shares of BeOne Medicines Ltd worth $24.5K as of Q2 2026.
  • GAMMA Investing bought 21 BeOne Medicines Ltd shares in Q2 2026, an estimated $6.19K.
  • BeOne Medicines Ltd made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2732 holding.
  • GAMMA Investing first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 11 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.